In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...
Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the specifics ...
Tempus AI’s moat on its healthcare diagnostics platform is being built around three main product lines, although revenue is mainly being driven by Genomics and Data. Diagnostic testing and ...
Analysts expect Tempus AI to post earnings of ($0.14) per share and revenue of $200.46 million for the quarter. Tempus AI Trading Up 0.3 % Shares of NASDAQ:TEM opened at $57.39 on Friday.
Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s stock price dropped 4.1% during trading on Monday following insider selling activity. The stock traded as low as $48.08 and last traded at $49.31.
Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...
Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14 ...
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against the other ...
Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results